Table 1.
Attributes and levels for the choice tasks.
Attributes | Description to patients | Levels and Level description | Abridged general view | |
---|---|---|---|---|
Progression-free survival | It refers to the time from the start of treatment until the tumor appears to be further deteriorated; this study fixes the overall survival and gives a choice of progression-free survival over time. | High Medium Low |
11 months 8 months 5 months |
![]() ![]() ![]() |
Disease control rate | The number of cases with remission and stable lesions after treatment accounted for the number of cases that could be evaluated. | High Medium Low |
90% 75% 60% |
![]() ![]() ![]() |
Rash | Treatments can cause a varying degrees rash for as long as you take the treatment. | None Mild Moderate |
No rash <1/10 of the body more than 1/3 of the body |
![]() ![]() ![]() |
Nausea and vomiting | Treatments can cause nausea and vomiting as long as you take the treatment. | Mild Moderate Severe |
1 time in 24 h 2–5 times in 24 h more than 6 times in 24 h |
![]() ![]() ![]() |
Weakness and fatigue | When you take the treatment you may feel even weaker or more tired. | Mild Moderate Severe |
It is difficult to do physical exercises such as climbing stairs or running. Can't work and take care of yourself. You need to remain in bed |
![]() ![]() ![]() |
Cost | How much will you pay for the treatment. | High Medium Low |
5 ten thousand per months 2.5 ten thousand per months 1 ten thousand per months |
![]() ![]() ![]() |
Mode of administration | In general, treatments can be administered by infusion or taken as pills. | Infusion Oral |
![]() ![]() |